multivariate model to predict the need for bone marrow sampling in patients with mgus
Published 1 year ago • 260 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
8:05
using ai to segment and classify bone marrow cells in patients with aml
-
0:52
using spatial proteomics to analyze the bone marrow microenvironment in smm treated with nivolumab
-
2:42
the importance of better identifying individuals with mgus & the possibility of treating precursors
-
5:04
the pangea model: improving risk stratification in multiple myeloma
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
18:16
identification of novel biomarkers for thyroid cancer through multi omics data analysis - by. cheena
-
2:16
what does the future of mgus look like?
-
3:24
an update on the pangea model
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
0:45
difference between quality of life & patient-reported outcomes
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
0:51
the pangea model: a novel dynamic model used to define disease progression in multiple myeloma
-
3:20
myeloma and the microenvironment
-
2:58
the promise of antibody-drug conjugates for the treatment of multiple myeloma
-
1:25
the value of treating mgus and smoldering myeloma patients with novel immunotherapies
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
1:16
using rwd to evaluate the use of fedratinib as a potential bridge to hsct in patients with mf
-
1:50
insights into the mechanisms leading to progression from mgus and smm to multiple myeloma
-
1:21
what is the pcrowd study, and how does knowledge in myeloma biology help with new treatments?
-
1:11
the pangea model: enhancing risk assessment for individuals with high-risk smoldering myeloma
-
2:11
unmet needs in bone marrow failure syndromes & myeloid malignancies: characterization & novel agents